From Screening to Treatment of Pancreatic Cancer: A Comprehensive Review
We present an in-depth analysis of the phase I-III clinical trials determining the role and efficacy of different modalities. We also describe rationale for future investigation.DISCUSSION: Despite advances in first-line and second-line therapies for APC, median OS remains short of a year. We need collaborative efforts between the cooperative groups, institutions, community practices and industry to work together in enrolling these patients in clinical trials. In addition to use new technologies, such as organoids, we must pay attention to the palliative aspect of care for these patients from the beginning including nutrit...
Source: Journal of the Pancreas - September 6, 2021 Category: Gastroenterology Authors: Muhammad Wasif Saif Source Type: research
